Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

PHASE3CompletedINTERVENTIONAL
Enrollment

1,759

Participants

Timeline

Start Date

August 30, 2016

Primary Completion Date

July 4, 2018

Study Completion Date

June 20, 2019

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Filgotinib

200 mg or 100 mg tablet(s) administered orally once daily

DRUG

Placebo to match filgotinib

Tablet(s) administered orally once daily

DRUG

Adalimumab

40 mg administered via subcutaneous injection once every two weeks

DRUG

Placebo to match adalimumab

Administered via subcutaneous injection once every two weeks

DRUG

MTX

Commercially sourced tablet(s) administered orally

Trial Locations (230)

Unknown

Huntsville

Phoenix

Tucson

Covina

Hemet

La Jolla

Palm Desert

Upland

Victorville

Whittier

Clearwater

DeBary

Jacksonville

Miami

Miami Lakes

New Port Richey

Orlando

Plantation

Kansas City

Wichita

Elizabethtown

Lexington

Cumberland

Hagerstown

Wheaton

Detroit

Saint Clair Shores

Eagan

Hattiesburg

Tupelo

St Louis

Toms River

Albuquerque

Salisbury

Bethlehem

Duncansville

Philadelphia

Wyomissing

Charleston

Columbia

Orangeburg

Memphis

Beaumont

Corpus Christi

Dallas

Mesquite

San Antonio

Webster

Buenos Aires

Caba

Mendoza

Quilmes

San Fernando

San Juan

San Miguel de Tucumán

Victoria Park

Brussels

Genk

Merksem

Dobrich

Haskovo

Plovdiv

Sofia

Varna

Vidin

Trois-Rivières

Prague

Brno

Ostrava

Ostrava-Poruba

Prague

Uherské Hradiště

Frankfurt A Main

Hamburg

Ratingen

Hong Kong

Kalocsa

Szentes

Székesfehérvár

Budapest

Eger

Ahmedabad

Bangalore

Chennai

Delhi

Gūrgaon

Hyderabad

Jaipur

Kolkata

Lucknow

Mangalore

Nagpur

New Delhi

Pune

Secunderabad

Srikakulam

Surat

Vadodara

Visakhapatnam

Dublin

Haifa

Tel Aviv

Tel Litwinsky

Bologna

Catania

Milan

Chiba

Fukuoka

Hiroshima

Iizuka-shi

Iruma-gun

Izumo

Kagoshima

Katō

Kitakyushu-shi

Kobe

Kumamoto

Kurume-shi

Kyoto

Miyazaki

Morioka

Nagaoka

Nagasaki

Nagoya

Narashino

Nishinomiya

Ōita

Sanuki-shi

Sapporo

Sasebo-shi

Sayama-shi

Shibata

Shinjuku-Ku

Shizuoka

Suita-shi

Takaoka

Takasaki-shi

Tokorozawa

Tokyo

Tsukuba

Wakayama

Yokohama

Mérida

Chihuahua City

Distrito Federal

Mexico City

Mérida

Monterrey

Morelia

Leiden

Papatoetoe

Auckland

Hamilton

Newtown

Timaru

Wroclaw

Bialystok

Bydgoszcz

Bytom

Elblag

Gdynia

Kartuzy

Katowice

Krakow

Nowa Sól

Poznan

Tomaszów Lubelski

Torun

Warsaw

Oradea

Bucharest

Bacau

Târgu Mureş

Barnaul

Chelyabinsk

Kazan'

Kemerovo

Moscow

Nizhny Novgorod

Saint Petersburg

Saratov

Vladimir

Yaroslavl

Belgrade

Niška Banja

Bratislava

Prievidza

Rimavská Sobota

Topoľčany

Cape Town

Durban

Johannesburg

Anyang-si

Busan

Daegu

Daejeon

Gwangju

Incheon

Jeonju

Seoul

A Coruña

Málaga

Sabadell

Santiago de Compostela

Valencia

Changhua

Kaohsiung City

Keelung

Taichung

Tainan City

Taipei

Taoyuan District

Bangkok

Chiang Mai

Songkhla

Dnipro

Kharkiv

Kherson

Kiev

Kyiv

Lutsk

Lviv

Odesa

Vinnytsia

Zaporizhzhya

Poole

Doncaster

Edinburgh

Newcastle upon Tyne

Warrington

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Galapagos NV

INDUSTRY

lead

Gilead Sciences

INDUSTRY